Literature DB >> 21517973

Limbal stem cell disease: management with scleral lenses.

Muriel M Schornack1.   

Abstract

BACKGROUND: Limbal stem cell deficiency (LSCD) results from damage to or destruction of corneal stem cells.
METHODS: A retrospective review of clinical records of a patient with LSCD describes the use of scleral lenses in disease management.
RESULTS: A patient presented with a one-year history of clinically diagnosed LSCD, which was worsening despite aggressive topical and systemic medical therapy. The condition resolved rapidly with initiation of scleral lens wear. The integrity of the ocular surface was maintained for 18 months even after the cessation of lens wear.
CONCLUSION: Scleral lenses might allow some patients with LSCD to delay or avoid more aggressive surgical intervention.
© 2011 Mayo Foundation for Medical Education and Research. Clinical and Experimental Optometry © 2011 Optometrists Association Australia.

Entities:  

Mesh:

Year:  2011        PMID: 21517973     DOI: 10.1111/j.1444-0938.2011.00618.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  7 in total

Review 1.  Contact Lens-induced Limbal Stem Cell Deficiency.

Authors:  Jennifer Rossen; Alec Amram; Behrad Milani; Dongwook Park; Jennifer Harthan; Charlotte Joslin; Timothy McMahon; Ali Djalilian
Journal:  Ocul Surf       Date:  2016-07-30       Impact factor: 5.033

Review 2.  Limbal and corneal epithelial homeostasis.

Authors:  Ghasem Yazdanpanah; Sayena Jabbehdari; Ali R Djalilian
Journal:  Curr Opin Ophthalmol       Date:  2017-07       Impact factor: 3.761

Review 3.  Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies.

Authors:  Michel Haagdorens; Sara Ilse Van Acker; Veerle Van Gerwen; Sorcha Ní Dhubhghaill; Carina Koppen; Marie-José Tassignon; Nadia Zakaria
Journal:  Stem Cells Int       Date:  2015-12-14       Impact factor: 5.443

4.  Large diameter scleral lens benefits for Asians with intractable ocular surface diseases: a prospective, single-arm clinical trial.

Authors:  Jayoon Moon; Sang-Mok Lee; Joon Young Hyon; Mee Kum Kim; Joo Youn Oh; Hyuk Jin Choi
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

5.  Regression of corneal opacity and neovascularization in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis with the use of prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.

Authors:  Jennifer Liao; Bita Asghari; Karen G Carrasquillo
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-14

Review 6.  Presentation, diagnosis and management of limbal stem cell deficiency.

Authors:  Kunjal Sejpal; Pejman Bakhtiari; Sophie X Deng
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

Review 7.  The Limbal Niche and Regenerative Strategies.

Authors:  Sohil Amin; Elmira Jalilian; Eitan Katz; Charlie Frank; Ghasem Yazdanpanah; Victor H Guaiquil; Mark I Rosenblatt; Ali R Djalilian
Journal:  Vision (Basel)       Date:  2021-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.